HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The impact of combination therapy with metformin and exogenous vitamin D on hypothalamic-pituitary-thyroid axis activity in women with autoimmune thyroiditis and high-normal thyrotropin levels.

AbstractWHAT IS KNOWN AND OBJECTIVE:
Metformin was found to decrease thyrotropin levels in subjects with non-autoimmune but not with autoimmune hypothyroidism. Vitamin D reduced thyroid autoimmunity without affecting thyrotropin and thyroid hormone levels. The aim of the current study was to investigate whether exogenous vitamin D modulates the impact of metformin on hypothalamic-pituitary-thyroid axis activity in young women with autoimmune thyroiditis.
METHODS:
This case-control study included 32 prediabetic women with Hashimoto's thyroiditis, high-normal thyrotropin levels (2.5-4.5 mIU/L) and vitamin D insufficiency. Based on patient preference, these individuals received either metformin (3 g daily) plus vitamin D (4000 IU daily) (n = 17) or were treated with only metformin (3 g daily) (n = 15). Plasma levels of glucose, serum levels of insulin, thyrotropin, total and free thyroid hormones and 25-hydroxyvitamin D, as well as serum titres of thyroid antibodies, were assessed at baseline and 6 months later.
RESULTS AND DISCUSSION:
Thirty-one women completed the study. At baseline, there were no differences between the treatment groups. In both study arms, metformin reduced plasma glucose levels and improved insulin sensitivity but this effect was stronger in subjects receiving vitamin D. Only metformin administered with vitamin D decreased thyrotropin levels, increased 25-hydroxyvitamin D levels and reduced thyroid antibody titres. The impact on thyrotropin and antibody titres correlated with the increase in 25-hydroxyvitamin D levels and with the improvement in insulin sensitivity.
WHAT IS NEW AND CONCLUSION:
This study has shown for the first time that exogenous vitamin D potentiates the impact of metformin on thyrotropin levels in women with autoimmune thyroiditis.
AuthorsRobert Krysiak, Karolina Kowalcze, Bogusław Okopień
JournalJournal of clinical pharmacy and therapeutics (J Clin Pharm Ther) Vol. 45 Issue 6 Pg. 1382-1389 (Dec 2020) ISSN: 1365-2710 [Electronic] England
PMID32706919 (Publication Type: Journal Article)
Copyright© 2020 John Wiley & Sons Ltd.
Chemical References
  • Blood Glucose
  • Thyroid Hormones
  • Vitamin D
  • Thyrotropin
  • Metformin
  • 25-hydroxyvitamin D
Topics
  • Adult
  • Blood Glucose (drug effects)
  • Case-Control Studies
  • Drug Synergism
  • Drug Therapy, Combination
  • Female
  • Hashimoto Disease (drug therapy)
  • Humans
  • Hypothalamo-Hypophyseal System (metabolism)
  • Insulin Resistance
  • Metformin (administration & dosage)
  • Middle Aged
  • Thyroid Hormones (blood)
  • Thyroiditis, Autoimmune (drug therapy)
  • Thyrotropin (blood)
  • Vitamin D (administration & dosage, analogs & derivatives, blood)
  • Vitamin D Deficiency (diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: